Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Appropriate Antibiotic Use for Acute Otitis Media
Your Article Summary
Somatostatin in medical management of chyle fistula after neck dissection for papillary thyroid carcinoma
American Journal of Otolaryngology, 08/20/09
Coskun A et al. – The authors present the case of a male patient with chyle fistula that was stopped completely within 24 hours after the somatostatin therapy. The use of somastostatin and its analogues in the treatment of chyle fistula is a new approach and has been documented in a few cases.
Today in Endocrine...keeping you current
Receive free subspecialty "5-minute updates" via email
Thyroid lymphoma and airway obstruction – is there a rationale for surgical management?
International Journal of Clinical Practice, 10/19/09
Geriatric Thyroidectomy
Archives of Otolaryngology, 10/23/09
Central Neck Dissection for Papillary Thyroid Cancer
Archives of Otolaryngology, 11/20/09
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: Results from a phase II prospective trial
Journal of Clinical Oncology, 11/25/09
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
The Lancet Oncology - Online First, 11/12/09
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck
Annals of Oncology, 11/10/09
Article Search
Sponsor


See Latest Articles


